Reduced Sdc1 and elevated HPSE presented in HG condition and after insulin treatment also offer some interpretations for the phenomenon that patients with type 2 diabetes have higher incidence of colorectal carcinoma, while insulin therapy may even increase this risk 25. This evidence concerns the gene SDC1 and type 2 diabetes mellitus.